New pill aims to slow Alzheimer's decline in major trial

NCT ID NCT06125951

Ongoing Disease control Sponsor: Actinogen Medical Source: ClinicalTrials.gov ↗

First seen Jan 04, 2026 · Last updated May 14, 2026 · Updated 16 times

Summary

This study tests whether a daily pill called Xanamem can safely help people with mild or moderate Alzheimer's dementia. About 247 adults aged 50 and older will receive either Xanamem or a placebo for 36 weeks, with an option to continue treatment for up to 108 weeks. The goal is to see if the drug improves thinking and daily function compared to a placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

ACW Investigative Site 101

Ivanhoe, Victoria, Australia
ACW Investigative Site 102

Kogarah, New South Wales, Australia
ACW Investigative Site 103

Erina, New South Wales, Australia
ACW Investigative Site 104

Nedlands, Western Australia, Australia
ACW Investigative Site 105

Chermside, Queensland, Australia
ACW Investigative Site 106

Darlinghurst, New South Wales, Australia
ACW Investigative Site 107

Macquarie Park, New South Wales, Australia
ACW Investigative Site 108

Malvern, Victoria, Australia
ACW Investigative Site 109

West Perth, Western Australia, Australia
ACW Investigative Site 110

Woodville South, South Australia, Australia
ACW Investigative Site 111

Newcastle, New South Wales, Australia
ACW Investigative Site 112

Parkville, Victoria, Australia
ACW Investigative Site 113

Birtinya, Queensland, Australia
ACW Investigative Site 114

Bedford Park, South Australia, Australia
ACW Investigative Site 115

Carlton, Victoria, Australia
ACW Investigative Site 203

Delray Beach, Florida, 33445, United States
ACW Investigative Site 206

Toms River, New Jersey, 08755, United States
ACW Investigative Site 207

Decatur, Georgia, 30030, United States
ACW Investigative Site 208

Englewood, Colorado, 80113, United States
ACW Investigative Site 209

Sherman Oaks, California, 91403, United States
ACW Investigative Site 210

Dayton, Ohio, 45459, United States
ACW Investigative Site 211

Denver, Colorado, 80218, United States
ACW Investigative Site 212

Portland, Oregon, 97225, United States
ACW Investigative Site 213

Orange, California, 92866, United States
ACW Investigative Site 214

Albany, New York, 12208, United States
ACW Investigative Site 215

Bellevue, Washington, 98007, United States
ACW Investigative Site 216

East Providence, Rhode Island, 02914, United States
ACW Investigative Site 217

Independence, Ohio, 44131, United States
ACW Investigative Site 218

Carlsbad, California, 92011, United States
ACW Investigative Site 219

Staten Island, New York, 10314, United States
ACW Investigative Site 220

Austin, Texas, 78757, United States
ACW Investigative site 201

Miami, Florida, 33176, United States
ACW Investigative site 202

New Port Richey, Florida, 34652, United States
ACW Investigative site 204

Orlando, Florida, 32803, United States
ACW Investigative site 205

The Villages, Florida, 32162, United States

Conditions

Explore the condition pages connected to this study.

ALZHEIMER DISEASE DEMENTIA MODERATE DEMENTIA, MILD